Page last updated: 2024-08-23

amineptin and Bulimia

amineptin has been researched along with Bulimia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brambilla, F; Brunetta, M; Draisci, A; Peirone, A2
Brambilla, F; Brunetta, M; Draisci, A; Manfredi, B; Panerai, AE; Peirone, A; Perna, G; Sacerdote, P1

Trials

2 trial(s) available for amineptin and Bulimia

ArticleYear
Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
    Neuropsychobiology, 1995, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Behavior Therapy; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Dibenzocycloheptenes; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Nutritional Physiological Phenomena; Psychiatric Status Rating Scales

1995
Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa.
    Neuropsychobiology, 1995, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Body Weight; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzocycloheptenes; Female; Fluvoxamine; Humans; Nutritional Physiological Phenomena; Psychiatric Status Rating Scales; Recurrence; Time Factors

1995

Other Studies

1 other study(ies) available for amineptin and Bulimia

ArticleYear
T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa.
    Psychiatry research, 1995, Nov-29, Volume: 59, Issue:1-2

    Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; beta-Endorphin; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzocycloheptenes; Female; Fluvoxamine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sincalide; T-Lymphocytes; Treatment Outcome

1995